IN THE SUMMER OF 2018, the movie Dying to Survive 我不是药神 stormed China’s domestic box office and sparked public discussion about the accessibility of medical treatment in China. The movie, which some film critics called ‘China’s Dallas Buyers’ Club’, is based on the true story of a leukemia patient smuggling in cheap anti-cancer drugs from India to help impoverished fellow patients who could not afford the expensive medication offered by Chinese hospitals. In the film, the smuggler is a divorced seller of Indian health supplements who does not have cancer himself. Within two weeks of opening in July, it had already become one of the highest grossing films in the history of Chinese cinema. The story resonated with Chinese people as it depicted how quickly even a middle-income family could be dragged into poverty by medical bills, and how being struck by illness and poverty at the same time can be devastating.